title: Surfactant therapy and intravenous zanamivir in severe respiratory failure due to persistent influenza A/H1N1 2009 virus infection.
authors.forename: Stefano
authors.initials: S
authors.lastname: Busani
authors.forename: Massimo
authors.initials: M
authors.lastname: Girardis
authors.forename: Emanuela
authors.initials: E
authors.lastname: Biagioni
authors.forename: Alberto
authors.initials: A
authors.lastname: Pasetto
authors.forename: Vittorio
authors.initials: V
authors.lastname: Sambri
mesh_terms: D000208:Acute Disease; D001688:Biological Products / Q000008:administration & dosage / Q000627:therapeutic use*; D001999:Bronchoscopy; D002648:Child; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy*; D007262:Infusions, Intravenous; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use*; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000188:drug therapy* / Q000209:etiology; D053243:Zanamivir / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D001688:Biological Products; D010743:Phospholipids; D011663:Pulmonary Surfactants; C068291:poractant alfa; D053243:Zanamivir